Trial of cannabis-based drug in brain tumour treatment given go ahead
A trial of the cannabis-based drug, Sativex, in treating aggressive brain tumours, has been given the green light. A Phase II trial of Sativex, in 27 patients with the most severe form of brain tumour, will open in 2022. The Brain Tumour Charity announced on Thursday 25 [...]